In cellular biology, the role of reactive oxygen species (ROS) has evolved from being perceived merely as harmful metabolic ...

In a heartfelt testament to the power of family and community, Amanda Busch, an oncology pharmacist and mother of two, shared ...

A recent study evaluates the dosing, safety, and efficacy of telaglenastat and azacytidine to treat advanced myelodysplastic ...

Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a late stage pharmaceutical company with a broad ...

Leukemia stem cells (LSCs) pose a significant challenge in treating acute myeloid leukemia (AML) due to their resistance to ...

A new editorial was published in Oncotarget's Volume 15 on October 1, 2024, entitled, "Transplant or no transplant for TP53 ...

Pacylex Pharmaceuticals Publishes a New Myristoylation Inhibitor Mechanism of Anti-Cancer Activity in Molecular Cancer Therapeutics ...

BUFFALO, NY- October 11, 2024 – A new editorial was published in Oncotarget's Volume 15 on October 1, 2024, entitled, ...

Stem-cell therapies often make the headlines. Visions of a medical revolution progressing health care past the need for ...

The following is a summary of “Venetoclax plus decitabine as a bridge to allogeneic haematopoietic stem-cell transplantation ...

Frank Goodman, 77, a retired lorry driver from Preston, received a stem cell transplant at the Manchester Royal Infirmary eight years ago, to treat Acute Myeloid Leukaemia. He was told that ...

Image credit: Costfoto/NurPhoto via Getty Images. A woman has undergone a stem-cell therapy made from her own cells, to treat her type 1 diabetes. Researchers in China discovered the woman did not ...